“Quality-by-Design Approach and Optimization of Risk Factors by Box-Behnken Design in Formulation Development of Aspirin and Glycine Orally Disintegrating Tablet” (2021) Journal of Scientific Research, 13(3), pp. 935–950. doi:10.3329/jsr.v13i3.51952.